se of azithromycin( an antibiotic) for duration of three months to control symptoms of asthma in children whose symptoms arenot controlled.
- Conditions
- Health Condition 1: J454- Moderate persistent asthmaHealth Condition 2: J455- Severe persistent asthma
- Registration Number
- CTRI/2019/06/019727
- Lead Sponsor
- Jagat Jeevan ghimire
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Children of 5-15 years of age with a diagnosis of poorly controlled asthma.
Children already diagnosed with asthma and following up regularly in Pediatric Chest Clinic or Pediatric OPD will be eligible for study. Asthma will be diagnosed clinically based on recurrent episodes of airway obstruction (cough, wheezing and /or breathing difficulty) with multiple triggers and reversibility by history or by positive bronchodilator response. Poorly controlled asthma will be defined as childhood Asthma control test (CACT) score of <= 19 in children 5-11 years of age and Asthma control test (ACT) score of <= 19 in children > 11 years of age.
1.Known allergic to macrolides.
2. Known case of liver, kidney, and/or neurological disease, heart disease.
3. Prolonged QTc interval
4. Received azithromycin within last 2 weeks.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.